Open AccessUpdated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial
Author(s) -
Dhruv S. Kazi,
Joanne Penko,
Pamela G. Coxson,
Andrew E. Moran,
Daniel A. Ollendorf,
Jeffrey A. Tice,
Kirsten BibbinsDomingo
Publication year - 2017
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2017.9924
Subject(s) - medicine , pcsk9 , clinical trial , cost effectiveness , fourier transform , cholesterol , risk analysis (engineering) , lipoprotein , ldl receptor , mathematical analysis , mathematics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom